IP Library Granted Patent US 11,256,096
Granted Patent B2
US 11,256,096 · App. 17/020,641 · Granted Feb 22, 2022

Methods and systems for diagnosing and treating presbyopia

Inventors: Nicole Elizabeth Samec (Fort Lauderdale, FL); John Graham Macnamara (Plantation, FL); Christopher M. Harrises (Nashua, NH); Brian T. Schowengerdt (Seattle, WA); Rony Abovitz (Weston, FL); Mark Baerenrodt (Millbrae, CA)
Assignee: Magic Leap, Inc.
G02B27/0172A61B3/005A61B3/0008A61B3/0025A61B3/022A61B3/024A61B3/028A61B3/063A61B3/066A61B3/08A61B3/085A61B3/10A61B3/102A61B3/1005A61B3/1015A61B3/1035A61B3/113A61B3/12A61B3/1216A61B3/1241A61B3/13A61B3/14A61B3/165A61B5/0059A61B5/1455A61B5/14532A61B5/14555A61B5/361A61B5/369A61B5/398A61B5/6803A61B8/10A61B8/461A61F9/0026A61M21/02G02B21/0032G02B27/0093G02B27/0179G06T19/006G16H40/63G16H40/67A61B5/0066A61B5/0077A61B5/01A61B2562/0204A61B2562/0219A61B2562/0247A61F2007/0004A61F2007/004A61F2009/00863A61H2201/165A61M2021/0022A61M2021/0027A61M2021/0066A61M2205/3375A61M2205/507A61N2005/0648G02B2027/014G02B2027/0138G02B2027/0185G02C7/027G06T2207/10024G06T2207/10148G06T2207/10152G06T2207/30041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,256,096
App. No.
17/020,641
Granted
Feb 22, 2022
Kind
B2
Abstract

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects.

Claims (12)

1. An augmented reality display device, the device comprising:

a wearable augmented reality display configured to pass light from the world into an eye of a person wearing the augmented reality display device, the augmented reality display comprising optics configured to output light to form an image in the eye,

wherein the augmented reality display is configured to output a first color component of the image with wavefront divergence corresponding to a first depth plane and a second color component of the image with wavefront divergence corresponding to a second depth plane different than the first depth plane to compensate for longitudinal chromatic aberration of the person's eye.

2. The device of claim 1 , wherein the augmented reality display is configured to output a third color component of the image with wavefront divergence corresponding to a third depth plane different than the first and second depth planes to compensate for longitudinal chromatic aberration of the person's eye.

3. The device of claim 1 , further comprising an interface configured to receive a prescription for the longitudinal chromatic aberration of the person's eye.

4. The device of claim 1 , configured to conduct an eye exam to determine a prescription for the longitudinal chromatic aberration of the person's eye wherein the eye exam comprises providing incremental changes in the prescription by automatically changing a wavefront divergence of light forming a monochromatic image of the first color component of the image and automatically changing a wavefront divergence of light forming a monochromatic image of the second color component.

5. The device of claim 4 , further comprising a biofeedback system that monitors one or more properties of the eye to determine the prescription by providing an input for the augmented reality display device, wherein the wavefront divergence is incrementally changed based on the input and wherein the one or more properties of the eye is at least one of: changes in a convergence point of the eye, changes in a position of a head of the person, and changes in a size of a pupil of the eye.

6. The device of claim 4 , further comprising a user interface configured to receive a user input from the person regarding whether the person can view the image comfortably; and incrementally increase the prescription, positive or negative, by changing the wavefront divergence of light forming a monochromatic images of the first and/or the second color components based at least in part on the user input.

7. The device of claim 1 , wherein the augmented reality display comprises an adaptable optics element configured to modify the image.

8. The device of claim 7 , wherein the adaptable optics element comprises a deformable mirror.

9. The device of claim 1 , wherein the augmented reality display comprises a waveguide stack comprising a plurality of waveguides configured to output light having wavefront divergence corresponding to different focal planes.

10. The device of claim 9 , wherein the number of waveguides in the stack of waveguides correspond to the number of color components.

Assignments (2)
SECURITY INTEREST Recorded May 24, 2022
From: MOLECULAR IMPRINTS, INC.; MENTOR ACQUISITION ONE, LLC; MAGIC LEAP, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 060338/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2021
From: SAMEC, NICOLE ELIZABETH; MACNAMARA, JOHN GRAHAM; SCHOWENGERDT, BRIAN T.; ABOVITZ, RONY; BAERENRODT, MARK; HARRISES, CHRISTOPHER M.
To: MAGIC LEAP, INC.
Reel/Frame 054819/0499 →
Continuity (5)
Continuation 16562302 · Sep 5, 2019
Continuation 15269335 · Sep 19, 2016
Continuation 15072290 · Mar 16, 2016
Provisional Application 62133870 · Mar 16, 2015
Related Publication 20200409159A1 · Dec 31, 2020
Cited By (3)
US 12,261,580 US 12,517,360 US 12,710,570